Posted on 1 September 20261 September 2026 Lilly’s Mounjaro wins US label expansion for cardiovascular risk reduction The US Food and Drug Administration (FDA) has approved Eli Lilly’s blockbuster type 2 diabetes therapy, Mounjaro (tirzepatide),...
